Epigenetic Reprogramming For Ocular Aging And Disease: Mechanisms, Biomarkers, And The Road To The Clinic
Our eyes, vital for perceiving the world, are susceptible to aging and diseases like glaucoma and age-related macular degeneration. These conditions are often linked to “epigenetic” changes, which are modifications to how our genes are expressed without altering the underlying DNA sequence itself. Think of it like changing the software that runs a computer, rather than changing the hardware. These epigenetic alterations can disrupt the normal functioning of eye cells, contributing to vision loss. However, unlike permanent genetic mutations, these epigenetic marks are reversible. Scientists are exploring a revolutionary approach called epigenetic reprogramming. This involves using specific factors, sometimes referred to as “Yamanaka factors,” or chemical mixtures to essentially “reset” these epigenetic changes. The goal is to restore eye cells to a more youthful and functional state. Early research, particularly in preclinical studies, has shown exciting potential, demonstrating the ability to restore vision in models of optic nerve damage. This new understanding of how our genes are regulated offers a fresh perspective on treating and potentially reversing age-related eye conditions, paving the way for innovative therapies in ophthalmology.
Source: link to paper